Loading...
XBKK
MEGA
Market cap814mUSD
Nov 12, Last price  
29.75THB
Name

Mega Lifesciences PCL

Chart & Performance

D1W1MN
XBKK:MEGA chart
P/E
12.89
P/S
1.69
EPS
2.31
Div Yield, %
5.38%
Shrs. gr., 5y
-0.03%
Rev. gr., 5y
6.63%
Revenues
15.34b
-2.15%
4,856,829,2975,964,777,1927,033,531,1017,730,049,0007,944,741,0008,810,230,0009,597,358,00010,341,601,00011,129,783,00012,589,411,00014,135,656,00015,686,224,00015,681,172,00015,344,136,000
Net income
2.01b
+0.99%
455,892,612555,604,222624,015,532547,880,000695,747,000794,909,0001,112,797,0001,206,008,0001,138,515,0001,392,651,0001,946,825,0002,241,529,0001,992,673,0002,012,481,000
CFO
2.40b
+24.65%
266,674,335342,019,548465,766,151614,217,000609,122,0001,260,448,000927,002,000919,359,0001,495,106,0001,629,428,0002,726,825,0001,996,625,0001,926,486,0002,401,377,000
Dividend
Aug 23, 20240.8 THB/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Mega Lifesciences Public Company Limited, together with its subsidiaries, manufactures, markets, and sells health food supplements, prescription pharmaceutical products, over-the-counter (OTC) products, herbal products, vitamins, and fast moving consumer goods. The company operates through Brands, Distribution, and Original Equipment Manufacture segments. It provides various complementary medicines for bone and joint, children, diabetic, heart, herbal, liver and digestive, skin, slimming, and well-being care, as well as men's and women's care products and sports supplements; gastrointestinal and pain care OTC medicines; and prescription medicines in the areas of iron supplement, anticoagulant, diabetology, cardiology, dermatology, gastroenterology, neurology, pain, osteoporosis, respiratory, urology, oncology, and nephrology. The company also offers logistical and marketing services for the sale of goods manufactured by third parties. In addition, the company engages in the operation of wellness center; and software design, development, and other services business. It operates in the Asia Pacific, the Middle East, Africa, and the Commonwealth of Independent States. The company was incorporated in 1982 and is headquartered in Bangkok, Thailand. Mega Lifesciences Public Company Limited is a subsidiary of Unistretch Limited.
IPO date
Nov 19, 2013
Employees
Domiciled in
TH
Incorporated in
TH

Valuation

Title
THB in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT